LabCompass

Megan Fleming

Medicine · The Ohio State University

OpenAlex ORCID
Early career · publishing since 2020
Acute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchCNS Lymphoma Diagnosis and TreatmentCancer Treatment and Pharmacology

Publications

11

Citations

38

Est. group size

~3

Recurring co-author estimate

Active years

6

Publishing since 2020

Research summary
AI-generated

Megan Fleming's work focuses on the practical, applied side of cancer treatment, particularly blood cancers (leukemia, lymphoma) and hematopoietic cell transplantation. Recent publications examine medication management topics such as drug interactions, antiemetic (anti-nausea) drug effectiveness, and oncology drug repository programs that help manage medication costs and access for cancer patients.

Hematologic malignancies (leukemia, lymphoma)Hematopoietic cell transplantationOncology pharmacy practiceDrug interaction and medication safety studiesCancer supportive care (antiemetics, symptom management)

Publication output has been modest but present over the last decade, with a small increase in activity from 2021 through 2025 compared to earlier years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
1718192020: 1 publication202021: 3 publications3212022: 1 publication222023: 1 publication232024: 2 publications242025: 3 publications32526
Recent publications
Publishes in
  • Blood×4
  • Clinical Breast Cancer×1
  • Blood Advances×1
  • Therapeutic Advances in Hematology×1
  • Journal of Oncology Pharmacy Practice×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile